|
|
|
Volumn 50, Issue 9, 2012, Pages 697-704
|
|
[Rituximab therapy for severe pediatric systemic lupus erythematosus].
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
CYCLOPHOSPHAMIDE;
GLUCOCORTICOID;
IMMUNOLOGIC FACTOR;
MONOCLONAL ANTIBODY;
PREDNISOLONE;
RITUXIMAB;
ADOLESCENT;
ARTICLE;
B LYMPHOCYTE;
BLOOD;
CHILD;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HUMAN;
IMMUNOLOGY;
LUPUS ERYTHEMATOSUS NEPHRITIS;
MALE;
PATHOLOGY;
PNEUMONIA;
PRESCHOOL CHILD;
SEVERITY OF ILLNESS INDEX;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TREATMENT OUTCOME;
ADOLESCENT;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
B-LYMPHOCYTES;
BIOLOGICAL MARKERS;
CHILD;
CHILD, PRESCHOOL;
CYCLOPHOSPHAMIDE;
FEMALE;
FOLLOW-UP STUDIES;
GLUCOCORTICOIDS;
HUMANS;
IMMUNOLOGIC FACTORS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
LUPUS NEPHRITIS;
MALE;
PNEUMONIA;
PREDNISOLONE;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
|
EID: 84875000377
PISSN: 05781310
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
